BL KASHYAP & SONS | HULTA PHARMA | BL KASHYAP & SONS/ HULTA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -488.6 | -15.4 | - | View Chart |
P/BV | x | 3.4 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
BL KASHYAP & SONS HULTA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BL KASHYAP & SONS Mar-23 |
HULTA PHARMA Mar-23 |
BL KASHYAP & SONS/ HULTA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 38 | 10 | 366.9% | |
Low | Rs | 17 | 3 | 561.7% | |
Sales per share (Unadj.) | Rs | 49.2 | 0 | - | |
Earnings per share (Unadj.) | Rs | 1.0 | -0.4 | -229.3% | |
Cash flow per share (Unadj.) | Rs | 1.4 | -0.4 | -330.2% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 19.7 | -1.2 | -1,643.8% | |
Shares outstanding (eoy) | m | 225.44 | 7.45 | 3,026.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0 | - | |
Avg P/E ratio | x | 28.1 | -15.7 | -178.6% | |
P/CF ratio (eoy) | x | 19.5 | -15.7 | -124.0% | |
Price / Book Value ratio | x | 1.4 | -5.6 | -24.9% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 6,217 | 50 | 12,412.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,876 | 1 | 176,950.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 11,100 | 0 | - | |
Other income | Rs m | 199 | 0 | - | |
Total revenues | Rs m | 11,299 | 0 | - | |
Gross profit | Rs m | 619 | -3 | -23,451.1% | |
Depreciation | Rs m | 97 | 0 | - | |
Interest | Rs m | 515 | 1 | 93,572.7% | |
Profit before tax | Rs m | 206 | -3 | -6,459.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -15 | 0 | - | |
Profit after tax | Rs m | 221 | -3 | -6,940.1% | |
Gross profit margin | % | 5.6 | 0 | - | |
Effective tax rate | % | -7.4 | 0 | - | |
Net profit margin | % | 2.0 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,617 | 0 | 2,404,270.0% | |
Current liabilities | Rs m | 7,062 | 0 | 6,420,281.8% | |
Net working cap to sales | % | 23.0 | 0 | - | |
Current ratio | x | 1.4 | 3.6 | 37.4% | |
Inventory Days | Days | 38 | 0 | - | |
Debtors Days | Days | 1,380 | 0 | - | |
Net fixed assets | Rs m | 2,485 | 0 | 753,097.0% | |
Share capital | Rs m | 225 | 75 | 302.5% | |
"Free" reserves | Rs m | 4,222 | -83 | -5,057.5% | |
Net worth | Rs m | 4,447 | -9 | -49,742.3% | |
Long term debt | Rs m | 357 | 10 | 3,730.8% | |
Total assets | Rs m | 12,102 | 1 | 1,657,849.3% | |
Interest coverage | x | 1.4 | -4.8 | -29.2% | |
Debt to equity ratio | x | 0.1 | -1.1 | -7.5% | |
Sales to assets ratio | x | 0.9 | 0 | - | |
Return on assets | % | 6.1 | -361.5 | -1.7% | |
Return on equity | % | 5.0 | 35.6 | 14.0% | |
Return on capital | % | 15.0 | -425.6 | -3.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 3 | 0 | - | |
Net fx | Rs m | -3 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 195 | -3 | -5,903.0% | |
From Investments | Rs m | 1,097 | NA | - | |
From Financial Activity | Rs m | -1,102 | 3 | -33,601.8% | |
Net Cashflow | Rs m | 190 | 0 | -634,966.7% |
Indian Promoters | % | 61.7 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 56.3 | - | |
Indian inst/Mut Fund | % | 0.9 | 1.1 | 86.0% | |
FIIs | % | 0.9 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 38.4 | 43.7 | 87.8% | |
Shareholders | 38,581 | 3,820 | 1,010.0% | ||
Pledged promoter(s) holding | % | 99.5 | 0.0 | - |
Compare BL KASHYAP & SONS With: DLF DB REALTY SUNTECK REALTY AJMERA REALTY PRESTIGE ESTATES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | BL KASHYAP & SONS | HULTA PHARMA | S&P BSE REALTY |
---|---|---|---|
1-Day | -1.67% | 4.86% | 0.53% |
1-Month | 1.61% | -15.75% | 8.59% |
1-Year | 73.32% | 58.32% | 117.98% |
3-Year CAGR | 59.10% | 24.48% | 45.19% |
5-Year CAGR | 28.25% | 0.53% | 29.95% |
* Compound Annual Growth Rate
Here are more details on the BL KASHYAP & SONS share price and the HULTA PHARMA share price.
Moving on to shareholding structures...
The promoters of BL KASHYAP & SONS hold a 61.7% stake in the company. In case of HULTA PHARMA the stake stands at 56.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BL KASHYAP & SONS and the shareholding pattern of HULTA PHARMA.
Finally, a word on dividends...
In the most recent financial year, BL KASHYAP & SONS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
HULTA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of BL KASHYAP & SONS, and the dividend history of HULTA PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.